CN115154403A - Skin repair composition and preparation method and application thereof - Google Patents
Skin repair composition and preparation method and application thereof Download PDFInfo
- Publication number
- CN115154403A CN115154403A CN202211028535.0A CN202211028535A CN115154403A CN 115154403 A CN115154403 A CN 115154403A CN 202211028535 A CN202211028535 A CN 202211028535A CN 115154403 A CN115154403 A CN 115154403A
- Authority
- CN
- China
- Prior art keywords
- parts
- skin
- ceramide
- extract
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 82
- 230000008439 repair process Effects 0.000 title claims abstract description 53
- 238000002360 preparation method Methods 0.000 title claims abstract description 30
- 239000000284 extract Substances 0.000 claims abstract description 54
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 claims abstract description 35
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 claims abstract description 35
- 229940106189 ceramide Drugs 0.000 claims abstract description 35
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 claims abstract description 35
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 claims abstract description 35
- 239000013543 active substance Substances 0.000 claims abstract description 33
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 24
- 229930014626 natural product Natural products 0.000 claims abstract description 11
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims abstract description 10
- BAWFJGJZGIEFAR-NNYOXOHSSA-N NAD zwitterion Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-N 0.000 claims abstract description 10
- 229950006238 nadide Drugs 0.000 claims abstract description 10
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 claims abstract description 10
- 229910052708 sodium Inorganic materials 0.000 claims abstract description 10
- 239000011734 sodium Substances 0.000 claims abstract description 10
- VVOAZFWZEDHOOU-UHFFFAOYSA-N honokiol Natural products OC1=CC=C(CC=C)C=C1C1=CC(CC=C)=CC=C1O VVOAZFWZEDHOOU-UHFFFAOYSA-N 0.000 claims description 32
- 238000002156 mixing Methods 0.000 claims description 22
- 238000003756 stirring Methods 0.000 claims description 22
- 239000004094 surface-active agent Substances 0.000 claims description 21
- 239000003921 oil Substances 0.000 claims description 20
- 230000003716 rejuvenation Effects 0.000 claims description 20
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 claims description 20
- 235000019198 oils Nutrition 0.000 claims description 19
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 claims description 18
- 150000002148 esters Chemical class 0.000 claims description 18
- 238000000034 method Methods 0.000 claims description 16
- BBAFBDLICMHBNU-MFZOPHKMSA-N N-(2-hydroxyoctadecanoyl)-4-hydroxysphinganine Chemical compound CCCCCCCCCCCCCCCCC(O)C(=O)N[C@@H](CO)[C@H](O)[C@H](O)CCCCCCCCCCCCCC BBAFBDLICMHBNU-MFZOPHKMSA-N 0.000 claims description 12
- KZTJQXAANJHSCE-OIDHKYIRSA-N N-octodecanoylsphinganine Chemical compound CCCCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)CCCCCCCCCCCCCCC KZTJQXAANJHSCE-OIDHKYIRSA-N 0.000 claims description 11
- ATGQXSBKTQANOH-UWVGARPKSA-N N-oleoylphytosphingosine Chemical compound CCCCCCCCCCCCCC[C@@H](O)[C@@H](O)[C@H](CO)NC(=O)CCCCCCC\C=C/CCCCCCCC ATGQXSBKTQANOH-UWVGARPKSA-N 0.000 claims description 11
- GCDXVKZXCQGDHC-BLCQCPAESA-N [30-oxo-30-[[(2s,3s,4r)-1,3,4-trihydroxyoctadecan-2-yl]amino]triacontyl] (9z,12z)-octadeca-9,12-dienoate Chemical compound CCCCCCCCCCCCCC[C@@H](O)[C@@H](O)[C@H](CO)NC(=O)CCCCCCCCCCCCCCCCCCCCCCCCCCCCCOC(=O)CCCCCCC\C=C/C\C=C/CCCCC GCDXVKZXCQGDHC-BLCQCPAESA-N 0.000 claims description 11
- 229940086668 ceramide eop Drugs 0.000 claims description 11
- 238000000855 fermentation Methods 0.000 claims description 11
- 230000004151 fermentation Effects 0.000 claims description 11
- 229920000223 polyglycerol Polymers 0.000 claims description 11
- 244000125300 Argania sideroxylon Species 0.000 claims description 10
- 241001071795 Gentiana Species 0.000 claims description 10
- 241001135917 Vitellaria paradoxa Species 0.000 claims description 10
- 235000018936 Vitellaria paradoxa Nutrition 0.000 claims description 10
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 claims description 10
- 229940057910 shea butter Drugs 0.000 claims description 10
- -1 sorbitan ester Chemical class 0.000 claims description 10
- 229940032094 squalane Drugs 0.000 claims description 10
- 206010020649 Hyperkeratosis Diseases 0.000 claims description 9
- 235000018330 Macadamia integrifolia Nutrition 0.000 claims description 9
- 240000000912 Macadamia tetraphylla Species 0.000 claims description 9
- 235000003800 Macadamia tetraphylla Nutrition 0.000 claims description 9
- 244000042664 Matricaria chamomilla Species 0.000 claims description 9
- 235000007232 Matricaria chamomilla Nutrition 0.000 claims description 9
- 240000007817 Olea europaea Species 0.000 claims description 9
- 241000589499 Thermus thermophilus Species 0.000 claims description 9
- 235000013399 edible fruits Nutrition 0.000 claims description 9
- FVYXIJYOAGAUQK-UHFFFAOYSA-N honokiol Chemical compound C1=C(CC=C)C(O)=CC=C1C1=CC(CC=C)=CC=C1O FVYXIJYOAGAUQK-UHFFFAOYSA-N 0.000 claims description 9
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 9
- 241000226556 Leontopodium alpinum Species 0.000 claims description 8
- BNMGUJRJUUDLHW-HLUHVYOBSA-N Madecassoside Natural products C[C@@H]1CC[C@@]2(CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)C[C@@H](O)[C@H](O)[C@@](C)(CO)[C@@H]5[C@H](O)C[C@@]34C)[C@@H]2[C@H]1C)C(=O)O[C@@H]6O[C@H](CO[C@@H]7O[C@H](CO)[C@@H](O[C@@H]8O[C@H](C)[C@H](O)[C@@H](O)[C@H]8O)[C@H](O)[C@H]7O)[C@@H](O)[C@H](O)[C@H]6O BNMGUJRJUUDLHW-HLUHVYOBSA-N 0.000 claims description 8
- BNMGUJRJUUDLHW-HCZMHFOYSA-N Madecassoside Chemical compound O([C@@H]1[C@@H](CO)O[C@H]([C@@H]([C@H]1O)O)OC[C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)OC(=O)[C@]12CC[C@H]([C@@H]([C@H]1C=1[C@@]([C@@]3(C[C@@H](O)[C@H]4[C@](C)(CO)[C@@H](O)[C@H](O)C[C@]4(C)[C@H]3CC=1)C)(C)CC2)C)C)[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O BNMGUJRJUUDLHW-HCZMHFOYSA-N 0.000 claims description 8
- QCYLIQBVLZBPNK-UHFFFAOYSA-N asiaticoside A Natural products O1C(C(=O)C(C)C)=CC(C)C(C2(C(OC(C)=O)CC34C5)C)C1CC2(C)C3CCC(C1(C)C)C45CCC1OC1OCC(O)C(O)C1O QCYLIQBVLZBPNK-UHFFFAOYSA-N 0.000 claims description 8
- 229940090813 madecassoside Drugs 0.000 claims description 8
- 229940049964 oleate Drugs 0.000 claims description 8
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims description 8
- ZUVCYFMOHFTGDM-UHFFFAOYSA-N hexadecyl dihydrogen phosphate Chemical compound CCCCCCCCCCCCCCCCOP(O)(O)=O ZUVCYFMOHFTGDM-UHFFFAOYSA-N 0.000 claims description 7
- 235000007866 Chamaemelum nobile Nutrition 0.000 claims description 6
- 241001537183 Hypecoum Species 0.000 claims description 6
- 235000016108 Argania sideroxylon Nutrition 0.000 claims description 5
- 240000003549 Brabejum stellatifolium Species 0.000 claims description 5
- 235000013698 Brabejum stellatifolium Nutrition 0.000 claims description 5
- IYFATESGLOUGBX-YVNJGZBMSA-N Sorbitan monopalmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O IYFATESGLOUGBX-YVNJGZBMSA-N 0.000 claims description 5
- 239000008168 almond oil Substances 0.000 claims description 5
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 claims description 5
- GDCJELDNRAWYTE-UHFFFAOYSA-N honokiol dimethyl ether Natural products C1=C(CC=C)C(OC)=CC=C1C1=CC(CC=C)=CC=C1OC GDCJELDNRAWYTE-UHFFFAOYSA-N 0.000 claims description 5
- 229950003429 sorbitan palmitate Drugs 0.000 claims description 5
- 229940015975 1,2-hexanediol Drugs 0.000 claims description 4
- BYTORXDZJWWIKR-UHFFFAOYSA-N Hinokiol Natural products CC(C)c1cc2CCC3C(C)(CO)C(O)CCC3(C)c2cc1O BYTORXDZJWWIKR-UHFFFAOYSA-N 0.000 claims description 4
- 239000004519 grease Substances 0.000 claims description 4
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 239000000463 material Substances 0.000 claims description 4
- 229910019142 PO4 Inorganic materials 0.000 claims description 3
- 229960000541 cetyl alcohol Drugs 0.000 claims description 3
- 229940060184 oil ingredients Drugs 0.000 claims description 3
- 239000010452 phosphate Substances 0.000 claims description 3
- 239000002994 raw material Substances 0.000 claims description 3
- 239000006071 cream Substances 0.000 claims description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 2
- 210000002966 serum Anatomy 0.000 claims description 2
- 235000017945 Matricaria Nutrition 0.000 claims 2
- 241000589596 Thermus Species 0.000 claims 1
- 108010030416 proteoliposomes Proteins 0.000 claims 1
- 238000010521 absorption reaction Methods 0.000 abstract description 11
- 230000000694 effects Effects 0.000 abstract description 11
- 230000004888 barrier function Effects 0.000 abstract description 9
- 239000005556 hormone Substances 0.000 abstract description 9
- 229940088597 hormone Drugs 0.000 abstract description 9
- 229940083542 sodium Drugs 0.000 abstract description 8
- 230000001419 dependent effect Effects 0.000 abstract description 7
- 201000004624 Dermatitis Diseases 0.000 abstract description 6
- 206010061218 Inflammation Diseases 0.000 abstract description 5
- 230000004054 inflammatory process Effects 0.000 abstract description 5
- 238000011068 loading method Methods 0.000 abstract description 5
- 230000003020 moisturizing effect Effects 0.000 abstract description 5
- 230000008591 skin barrier function Effects 0.000 abstract description 5
- 230000005808 skin problem Effects 0.000 abstract description 5
- 230000002195 synergetic effect Effects 0.000 abstract description 5
- 230000003467 diminishing effect Effects 0.000 abstract description 4
- 230000001502 supplementing effect Effects 0.000 abstract description 4
- 230000035945 sensitivity Effects 0.000 abstract description 3
- 230000037394 skin elasticity Effects 0.000 abstract description 2
- 210000003491 skin Anatomy 0.000 description 117
- 238000012360 testing method Methods 0.000 description 38
- 230000000052 comparative effect Effects 0.000 description 21
- 230000008859 change Effects 0.000 description 11
- 239000000047 product Substances 0.000 description 11
- 206010015150 Erythema Diseases 0.000 description 10
- 208000003251 Pruritus Diseases 0.000 description 10
- 210000000434 stratum corneum Anatomy 0.000 description 10
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 9
- 229960001660 histamine phosphate Drugs 0.000 description 9
- ZHIBQGJKHVBLJJ-UHFFFAOYSA-N histamine phosphate Chemical compound OP(O)(O)=O.OP(O)(O)=O.NCCC1=CNC=N1 ZHIBQGJKHVBLJJ-UHFFFAOYSA-N 0.000 description 9
- 241000700198 Cavia Species 0.000 description 8
- 230000001815 facial effect Effects 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 108020004414 DNA Proteins 0.000 description 7
- 210000003711 chorioallantoic membrane Anatomy 0.000 description 7
- 239000000523 sample Substances 0.000 description 7
- 210000003837 chick embryo Anatomy 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 238000000338 in vitro Methods 0.000 description 6
- 239000010466 nut oil Substances 0.000 description 6
- 230000000638 stimulation Effects 0.000 description 6
- 241000287828 Gallus gallus Species 0.000 description 5
- 235000013330 chicken meat Nutrition 0.000 description 5
- 239000002537 cosmetic Substances 0.000 description 5
- 238000010586 diagram Methods 0.000 description 5
- 235000019488 nut oil Nutrition 0.000 description 5
- 241000700199 Cavia porcellus Species 0.000 description 4
- 241001534815 Hypsizygus marmoreus Species 0.000 description 4
- 229940012466 egg shell membrane Drugs 0.000 description 4
- 210000000548 hind-foot Anatomy 0.000 description 4
- 230000036571 hydration Effects 0.000 description 4
- 238000006703 hydration reaction Methods 0.000 description 4
- 210000004379 membrane Anatomy 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N EtOH Substances CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 206010040844 Skin exfoliation Diseases 0.000 description 3
- 210000001643 allantois Anatomy 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 230000018044 dehydration Effects 0.000 description 3
- 238000006297 dehydration reaction Methods 0.000 description 3
- 210000002257 embryonic structure Anatomy 0.000 description 3
- 238000001704 evaporation Methods 0.000 description 3
- 230000008020 evaporation Effects 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 229920000832 Cutin Polymers 0.000 description 2
- 206010012442 Dermatitis contact Diseases 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 206010040880 Skin irritation Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 210000000270 basal cell Anatomy 0.000 description 2
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000006835 compression Effects 0.000 description 2
- 238000007906 compression Methods 0.000 description 2
- 208000010247 contact dermatitis Diseases 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- 230000035618 desquamation Effects 0.000 description 2
- 210000003278 egg shell Anatomy 0.000 description 2
- 235000013601 eggs Nutrition 0.000 description 2
- 231100000321 erythema Toxicity 0.000 description 2
- 230000007717 exclusion Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000008707 rearrangement Effects 0.000 description 2
- 238000006748 scratching Methods 0.000 description 2
- 230000002393 scratching effect Effects 0.000 description 2
- 210000002374 sebum Anatomy 0.000 description 2
- 231100000475 skin irritation Toxicity 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 238000002834 transmittance Methods 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 206010015946 Eye irritation Diseases 0.000 description 1
- 241001135871 Gentiana scabra Species 0.000 description 1
- 241000208467 Macadamia Species 0.000 description 1
- 241000123069 Ocyurus chrysurus Species 0.000 description 1
- 244000137852 Petrea volubilis Species 0.000 description 1
- 208000012641 Pigmentation disease Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 208000032400 Retinal pigmentation Diseases 0.000 description 1
- 206010040799 Skin atrophy Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 206010043189 Telangiectasia Diseases 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 210000001142 back Anatomy 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 230000015624 blood vessel development Effects 0.000 description 1
- 229960002504 capsaicin Drugs 0.000 description 1
- 235000017663 capsaicin Nutrition 0.000 description 1
- 229940119217 chamomile extract Drugs 0.000 description 1
- 235000020221 chamomile extract Nutrition 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 231100000013 eye irritation Toxicity 0.000 description 1
- 238000005562 fading Methods 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 235000021588 free fatty acids Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 108010084652 homeobox protein PITX1 Proteins 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000001294 liquid chromatography-tandem mass spectrometry Methods 0.000 description 1
- 239000004973 liquid crystal related substance Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 231100000286 mucous membrane, eye irritation or corrosion testing Toxicity 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 230000037368 penetrate the skin Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 229940094541 polyglycerin-10 Drugs 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 201000004700 rosacea Diseases 0.000 description 1
- 238000011076 safety test Methods 0.000 description 1
- 230000037307 sensitive skin Effects 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 230000036620 skin dryness Effects 0.000 description 1
- 230000037067 skin hydration Effects 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000046 skin rash Toxicity 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000002344 surface layer Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 208000009056 telangiectasis Diseases 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/14—Liposomes; Vesicles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/31—Hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/347—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/39—Derivatives containing from 2 to 10 oxyalkylene groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/55—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/602—Glycosides, e.g. rutin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/606—Nucleosides; Nucleotides; Nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/673—Vitamin B group
- A61K8/675—Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/68—Sphingolipids, e.g. ceramides, cerebrosides, gangliosides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/86—Polyethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/005—Preparations for sensitive skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/56—Compounds, absorbed onto or entrapped into a solid carrier, e.g. encapsulated perfumes, inclusion compounds, sustained release forms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Cosmetics (AREA)
Abstract
The invention provides a skin repair composition and a preparation method and application thereof, wherein the skin repair composition comprises a deformed vesicle, water and active substances loaded in the deformed vesicle, and the active substances comprise DNA sodium, nicotinamide adenine dinucleotide, ceramide and natural product extracts. The skin repair composition provided by the invention can increase the transdermal absorption of the skin by loading the active substance in the deformed vesicle; the barrier repair effect of the skin is enhanced by four factors of relieving, diminishing inflammation, supplementing and rebuilding; the active substances are matched with each other, have a synergistic effect, have a strong moisturizing effect, enhance the skin elasticity, enhance the skin barrier function, improve the self-protection capability of the skin, reduce the skin sensitivity, have fresh and cool skin feeling without greasiness, and can effectively improve the skin problems of patients with hormone dependent dermatitis.
Description
Technical Field
The invention belongs to the technical field of cosmetics, and particularly relates to a skin repair composition as well as a preparation method and application thereof.
Background
The world health organization (WTO) has reported that: "in modern people, skin is less than 20% healthy, more than 20% sick, and in between 70% of sub-healthy skin population".
Sensitive skin is a sub-healthy state of the skin, and is mainly characterized in that the tolerance threshold of the skin is lowered, and the skin is easily stimulated by various internal and external factors to have uncomfortable feelings such as pruritus, burning, irritation, dryness or tightness, and occasionally accompanied by erythema, desquamation and the like. Factors causing skin sensitivity mainly include:
(1) Drying and water shortage: after the moisture on the surface layer of the skin is lost, the skin can have the problems of roughness, pruritus, chapping, desquamation and the like; if the skin is lacked for a long time, the skin is cracked, so that the barrier is damaged, and the health of the skin is influenced;
(2) External pollution: the stimulation of external adverse environments such as ultraviolet rays, automobile exhaust, dust in air, microorganisms and the like easily causes pigment precipitation, water-oil imbalance and sensitive stimulation reaction in a short time; the collagen in the skin is easily excessively lost, the cells are damaged, the immunity of the skin is weakened, and the aging process of the skin is accelerated;
(3) Poor skin care: the skin is excessively cleaned and the disinfection product is used, the balance of flora on the surface of the skin is easily influenced, the skin barrier is easily damaged due to excessive cutin removal, and hormone medicines are irregularly used for a long time; the long-term use of the hormone-containing cosmetics by consumers can generate dependence on the hormone, and can induce non-suppurative inflammatory reaction of skin to cause contact dermatitis once the cosmetics are stopped, and phenomena of facial telangiectasia erythema, pimple, facial skin atrophy, rosacea-like skin rash, pigmentation and the like, namely hormone-dependent dermatitis, appear.
(4) Physiological reasons are as follows: the self-metabolism is reduced, the body immunity is reduced, the skin tolerance is reduced, skin cells are easy to be stimulated by the outside, and the phenomena of redness, fever, pruritus, stabbing pain, erythra and the like are generated.
Therefore, how to provide a composition with soothing effect, so that the composition can enhance the skin barrier function and repair damaged skin, is a problem to be solved at present.
Disclosure of Invention
Aiming at the defects of the prior art, the invention aims to provide a skin repair composition and a preparation method and application thereof. The skin repair composition provided by the invention increases the repair effect of skin from four factors of relieving, diminishing inflammation, supplementing and rebuilding, has the characteristics of naturalness, mildness and high safety, has a strong barrier repair effect, is easy to be absorbed by skin, has a wide application range, can effectively improve the skin problem of a patient suffering from hormone dependent dermatitis, and can repair the skin damage problem after skin metabolism.
In order to achieve the purpose, the invention adopts the following technical scheme:
in a first aspect, the present invention provides a skin repair composition comprising an amoebosome, water, and an active agent loaded in the amoebosome, the active agent comprising sodium DNA, nicotinamide adenine dinucleotide, ceramide, and a natural product extract.
Cholesterol, ceramide and free fatty acid are the most main components of the synthetic sebum membrane, and the skin repair composition is prepared from four factors of relieving, diminishing inflammation, supplementing and reconstructing according to the characteristics of the sebum membrane. The skin modification composition provided by the invention has the characteristics of being natural and mild, high in safety, strong in barrier repair effect, easy to absorb by skin, wide in application range and capable of effectively improving the skin problems of patients suffering hormone-dependent dermatitis.
In the present invention, the skin repair composition comprises, in parts by weight, 11 to 27 parts (for example, 11 parts, 13 parts, 15 parts, 17 parts, 19 parts, 21 parts, 23 parts, 25 parts, 27 parts, etc.) of the deformed vesicle, 2 to 54 parts (for example, 2 parts, 5 parts, 10 parts, 15 parts, 20 parts, 25 parts, 30 parts, 35 parts, 40 parts, 45 parts, 50 parts, 54 parts, etc.) of water, and 35 to 88 parts (for example, 35 parts, 40 parts, 45 parts, 50 parts, 55 parts, 60 parts, 65 parts, 70 parts, 75 parts, 80 parts, 88 parts, etc.) of an active substance loaded in the deformed vesicle.
Preferably, the active substance comprises 0.5-1 part (for example, 0.5 part, 0.6 part, 0.7 part, 0.8 part, 0.9 part, 1 part and the like) of DNA sodium, 0.5-1 part (for example, 0.5 part, 0.6 part, 0.7 part, 0.8 part, 0.9 part, 1 part and the like) of nicotinamide adenine dinucleotide, 2.5-5 parts (for example, 2.5 parts, 3 parts, 3.5 parts, 4 parts, 4.5 parts, 5 parts and the like) of ceramide and 17-40 parts (for example, 17 parts, 20 parts, 25 parts, 30 parts, 35 parts, 40 parts and the like) of natural product extract by weight.
In the present invention, the natural product extract includes any one or a combination of at least two of madecassoside, leontopodium alpinum callus extract, hypsizygus marmoreus extract, thermus thermophilus fermentation product, gentian root extract, or chamomile flower extract, preferably a combination of madecassoside, leontopodium alpinum callus extract, hypsizygus marmoreus extract, thermus thermophilus fermentation product, gentian root extract, and chamomile flower extract.
Preferably, the first and second liquid crystal display panels are, the natural product extract includes 5 to 15 parts (e.g., 5 parts, 6 parts, 7 parts, 8 parts, 9 parts, 10 parts, 11 parts, 12 parts, 13 parts, 14 parts, 15 parts, etc.) of madder callus extract (e.g., 5 parts, 6 parts, 7 parts, 8 parts, 9 parts, 10 parts, 11 parts, 12 parts, 13 parts, 14 parts, 15 parts, etc.), 0.5 to 1 part (e.g., 0.5 part, 0.6 part, 0.7 part, 0.8 part, 0.9 part, 1 part, etc.) of hypecoum extract, 1 to 3 parts (e.g., 1 part, 1.5 part, 2 parts, 2.5 parts, 3 parts, etc.) of thermophilic bacteria fermentation product, 0.5 to 1 part (e.g., 0.5 part, 0.6 part, 0.7 part, 0.8 part, 0.9 part, 1 part, 0.5 part, 2.5 part, 3 parts, etc.) of gentian extract, 0.5 to 1 part (e.5 parts, 0.6 parts, 0.7 parts, 0.8 parts, 0.9 parts, etc.) of mother extract, 0.5 parts, 0.6 parts, 0.9 parts, etc.) and 0.5 parts of chrysanthemum extract, 0.9 parts, etc.) in parts by weight, etc. parts by weight.
In the present invention, the ceramide includes any one of or a combination of at least two of ceramide NS/ceramide NG, ceramide NP, ceramide EOP, ceramide AS, or ceramide AP, preferably a combination of ceramide NS/ceramide NG, ceramide NP, ceramide EOP, ceramide AS, and ceramide AP.
Preferably, the ceramide includes, in parts by weight, 0.5 to 1 part (e.g., may be 0.5 part, 0.6 part, 0.7 part, 0.8 part, 0.9 part, 1 part, etc.) of ceramide AS, and 0.5 to 1 part (e.g., may be 0.5 part, 0.6 part, 0.7 part, 0.8 part, 0.9 part, 1 part, etc.) of ceramide AP.
In the present invention, the active substance further includes a fat.
Preferably, the oil comprises any one or a combination of at least two of olive fruit oil, argan nut oil, squalane, shea butter or macadamia nut seed oil, preferably a combination of olive fruit oil, argan nut oil, squalane, shea butter and macadamia nut seed oil.
The skin repair composition provided by the invention is natural and mild, takes olive oil, argania spinosa kernel oil, squalane, shea butter and macadamia nut seed oil as basic grease, is used as an integral framework of the composition, enhances the effect of repairing damaged skin of the composition, has high safety, has a strong moisturizing effect, is easy to absorb by skin, has fresh and non-greasy skin feeling when used, and can effectively improve the skin problem of a patient suffering from hormone-dependent dermatitis.
Preferably, the first and second electrodes are formed of a metal, the oil comprises, by weight, 5 to 10 parts (for example, 5 parts, 5.5 parts, 6 parts, 6.5 parts, 7 parts, 7.5 parts, 8 parts, 8.5 parts, 9 parts, 9.5 parts, 10 parts, etc.), 5 to 10 parts (for example, 1 part, 2 parts, 3 parts, 4 parts, 5 parts, etc.) of shea butter, 1 to 5 parts (for example, 1 part, 2 parts, 3 parts, 4 parts, 5 parts, etc.) and 1 to 5 parts (for example, 1 to 5 parts, 2 parts, 3 parts, 4 parts, 5 parts, etc.) of macadamia seed oil.
Preferably, the active substance further comprises 1, 2-hexanediol.
Preferably, the active substance also comprises 2-5 parts (for example, 2 parts, 2.5 parts, 3 parts, 3.5 parts, 4 parts, 4.5 parts, 5 parts and the like) of 1, 2-hexanediol.
In the invention, the raw materials for preparing the proteosome comprise PEG/PPG-14/7 dimethyl ether, polyglycerol ester surfactant, sorbitan ester surfactant, cetyl alcohol phosphate, honokiol and magnolol.
Preferably, the raw materials for preparing the proteosome comprise 2-5 parts (such as 2 parts, 2.5 parts, 3 parts, 3.5 parts, 4 parts, 4.5 parts, 5 parts and the like) of PEG/PPG-14/7 dimethyl ether, 4-10 parts (such as 4 parts, 5 parts, 6 parts, 7 parts, 8 parts, 9 parts, 10 parts and the like) of polyglycerol ester surfactants, 2-5 parts (such as 2 parts, 2.5 parts, 3 parts, 3.5 parts, 4 parts, 4.5 parts, 5 parts and the like) of sorbitan ester surfactants, 1-3 parts (such as 1 part, 1.5 parts, 2 parts, 2.5 parts, 3 parts and the like) of cetyl alcohol phosphate ester, 1-2 parts (such as 1 part, 1.2 parts, 1.4 parts, 1.6 parts, 1.8 parts, 2 parts and the like) of magnolol and 1-2 parts (such as 1 part, 1.2 parts, 1.4 parts, 1.6 parts, 1.8 parts, 2 parts and the like) of magnolol.
Preferably, the polyglycerol ester surfactant comprises a polyglycerol-6 ester and/or polyglycerol-10 oleate of wild almond oil, preferably a combination of polyglycerol-6 ester and polyglycerol-10 oleate of wild almond oil.
Preferably, the sorbitan ester surfactant comprises sorbitan palmitate.
Preferably, the mass ratio of the magnolol to the polyglycerol ester-based surfactant is 1 (2-10) (wherein "2-10" may be 2, 3, 4, 5, 6, 7, 8, 9, 10, etc.).
In the invention, glycerin and natural oil are utilized to form a bilayer through a chemical synthesis method, so as to obtain polyglycerin (wild almond oil polyglycerin-6 esters and polyglycerin-10 oleate); the sorbitan ester surfactant is added to form a bilayer of the deformed vesicle, so that membrane permeability, encapsulation efficiency and bilayer rigidity are influenced; adding cetyl phosphate to ensure stability; honokiol and magnolol are added to adjust the stability, shape, size and other properties of the bilayer, which are determined by the mass ratio of magnolol and polyglycerol-based surfactant.
In the deformed vesicle, the bilayer is completely free of phospholipids and contains only single-chain surfactants, with maximum elasticity and deformability, and thus maximum transdermal capacity.
Because the deformed vesicles are highly hydrophilic vesicles, attempts are always made to avoid dehydration; when applied to the skin, vesicles tend to penetrate the skin barrier, moving to a deep layer rich in moisture, ensuring adequate hydration of the vesicle itself. The mechanism of penetration is that evaporation of water produces an "osmotic gradient" when the deformed vesicles are applied to the skin surface, and thus the transport of these elastic vesicles is not concentration-dependent.
In a second aspect, the present invention provides a method of preparing a skin rejuvenating composition according to the first aspect, the method comprising the steps of: mixing the deformed vesicle, water and the active substance, stirring and homogenizing to obtain the skin repair composition.
In the present invention, the mixing temperature is 35-45 ℃ (for example, 35 ℃, 37 ℃, 39 ℃, 41 ℃, 43 ℃, 45 ℃ and the like can be used).
Preferably, the stirring speed is 50-70rpm (for example, 50rpm, 53rpm, 56rpm, 59rpm, 61rpm, 64rpm, 67rpm, 70rpm, etc.) and the time is 0.8-1.2h (for example, 0.8h, 0.9h, 1h, 1.1h, 1.2h, etc.).
Preferably, the homogenizing speed is 4500-5500rpm (e.g. 4500rpm, 4700rpm, 4900rpm, 5000rpm, 5200rpm, 5400rpm, 5500rpm, etc.) and the time is 4-6min (e.g. 4min, 4.3min, 4.6min, 4.9min, 5.1min, 5.4min, 5.7min, 6min, etc.).
In the present invention, the method for preparing the deformed vesicle comprises the following steps:
(1) Mixing polyglycerol ester surfactant, sorbitan ester surfactant and cetyl phosphate, and stirring to obtain bilayer;
(2) And (2) mixing the bilayer obtained in the step (1), PEG/PPG-14/7 dimethyl ether, honokiol and magnolol, and stirring to obtain the deformed vesicle.
Preferably, in step (1), the temperature of the mixing is 55-65 ℃ (for example, 55 ℃, 57 ℃, 59 ℃, 61 ℃, 63 ℃, 65 ℃ and the like can be used).
Preferably, in step (1), the rotation speed of the stirring is 45-55rpm (for example, 45rpm, 47rpm, 49rpm, 51rpm, 53rpm, 55rpm, etc.), and the time is 20-40min (for example, 20min, 23min, 26min, 29min, 31min, 34min, 37min, 40min, etc.).
Preferably, in step (2), the temperature of the mixing is 40-50 ℃ (for example, 40 ℃, 42 ℃, 46 ℃, 48 ℃, 50 ℃ and the like can be realized).
Preferably, in step (2), the rotation speed of the stirring is 35-45rpm (for example, 35rpm, 37rpm, 39rpm, 41rpm, 43rpm, 45rpm, etc.), and the time is 20-40min (for example, 20min, 23min, 26min, 29min, 31min, 34min, 37min, 40min, etc.).
In a third aspect, the present invention provides a use of the skin repair composition according to the first aspect in the preparation of a skin care product.
Preferably, the skin care product comprises a cream and/or a serum.
Compared with the prior art, the invention has the following beneficial effects:
(1) The skin repair composition provided by the invention can increase the transdermal absorption of the skin by loading the active substance into the deformed vesicle; the four factors of relieving, diminishing inflammation, supplementing and reconstructing are adopted, and the barrier repair effect of the skin is enhanced;
(2) The active substances are matched with each other, have a synergistic effect, have a strong moisturizing effect, enhance the skin elasticity, enhance the skin barrier function, improve the self-protection capability of the skin, reduce the skin sensitivity, have fresh and cool skin feeling without greasiness, and can effectively improve the skin problems of patients suffering from hormone dependent dermatitis;
(3) All components in the active substance are mutually matched and have synergistic effect, so that nutrients are provided for basal cells of the skin, the division of the basal cells of the skin is promoted, the formation of new cutin is accelerated, and the effect of repairing the damaged skin can be finally achieved;
(4) The skin repair composition provided by the invention is high in safety, natural and mild;
(5) The preparation method of the skin repair composition provided by the invention has the characteristics of simple operation, convenient control, high production efficiency and low production cost, and can be used for large-scale production.
(6) The skin repair composition provided by the invention can improve the hydration of the skin, and has the advantages of exogenous hydration of stratum corneum (large amount of water), dehydration of stratum corneum (water evaporation), compression rearrangement of stratum corneum structure (compact and ordered), enhancement of stratum corneum barrier function (better resistance to external stimuli)/higher light transmittance (smooth and transparent appearance).
Drawings
FIG. 1 is a diagram of an in vitro transdermal absorption experiment of free fluorescein.
FIG. 2 is a diagram of an in vitro transdermal absorption experiment of fluorescein encapsulated in a deformed vesicle.
FIG. 3 is a diagram showing the stratum corneum alignment process.
Detailed Description
The technical solution of the present invention is further described below by way of specific embodiments. It should be understood by those skilled in the art that the examples are only for the understanding of the present invention and should not be construed as the specific limitations of the present invention.
Example 1
The embodiment provides a skin repair composition, which comprises the following components in parts by weight:
the preparation method of the skin repair composition comprises the following steps:
(1) Mixing oleum Armeniacae amarum polyglycerol-6 esters, polyglycerol-10 oleate, sorbitan palmitate and cetyl phosphate at 60 deg.C, stirring at 50rpm for 30min to obtain bilayer;
(2) Mixing the bilayer obtained in the step (1), PEG/PPG-14/7 dimethyl ether, honokiol and magnolol at 45 ℃, and stirring at the rotating speed of 40rpm for 30min; obtaining the deformed vesicle;
(3) Mixing the deformed vesicle obtained in the step (2), water and an active substance at 40 ℃, and stirring for 1h at the rotating speed of 60 rpm; and homogenizing at 5000rpm for 5min to obtain the skin repairing composition.
Example 2
The embodiment provides a skin repair composition, which comprises the following components in parts by weight:
the preparation method of the skin repair composition comprises the following steps:
(1) Mixing oleum Armeniacae amarum polyglycerol-6 esters, polyglycerol-10 oleate, sorbitan palmitate and cetyl phosphate at 55 deg.C, stirring at 55rpm for 20min to obtain bilayer;
(2) Mixing the bilayer obtained in the step (1), PEG/PPG-14/7 dimethyl ether, honokiol and magnolol at 40 ℃, and stirring at the rotation speed of 45rpm for 20min; obtaining the deformed vesicle;
(3) Mixing the deformed vesicle obtained in the step (2), water and active substances at 35 ℃, and stirring for 1.2h at the rotating speed of 50 rpm; homogenizing at 4500rpm for 4min to obtain the skin repairing composition.
Example 3
The embodiment provides a skin repair composition, which comprises the following components in parts by weight:
the preparation method of the skin repair composition comprises the following steps:
(1) Mixing oleum Armeniacae amarum polyglycerol-6 esters, polyglycerol-10 oleate, sorbitan palmitate and cetyl phosphate at 65 deg.C, stirring at 45rpm for 40min to obtain bilayer;
(2) Mixing the bilayer obtained in the step (1), PEG/PPG-14/7 dimethyl ether, honokiol and magnolol at 50 ℃, and stirring at the rotation speed of 35rpm for 40min; obtaining the deformed vesicle;
(3) Mixing the deformed vesicle obtained in the step (2), water and active substances at 45 ℃, and stirring for 0.8h at the rotating speed of 70 rpm; and homogenizing at 5500rpm for 6min to obtain the skin repairing composition.
Example 4
This example provides a skin-repairing composition, which is different from example 1 only in that it does not contain madecassoside, the weight part of the edelweiss callus extract is increased to 20 parts, and the other components and preparation method are the same as example 1.
Example 5
This example provides a skin rejuvenating composition, which is different from example 1 only in that it does not contain alpine edelweiss callus extract, the weight part of madecassoside is increased to 20 parts, and other components and preparation method are the same as example 1.
Example 6
This example provides a skin repair composition, which is different from example 1 only in that it does not contain hypsizygus marmoreus extract, the weight part of thermus thermophilus fermentation product is increased to 2.4 parts, the weight part of gentian root extract is increased to 1.2 parts, the weight part of chamomile extract is increased to 1.2 parts, and other components and preparation methods are the same as example 1.
Example 7
This example provides a skin repair composition, which is different from example 1 only in that, without the fermentation product of thermus thermophilus, the parts by weight of the hypecoum extract are increased to 1.6 parts, the parts by weight of the gentian root extract are increased to 1.6 parts, the parts by weight of the chamomile flower extract are increased to 1.6 parts, and other components and preparation methods are the same as example 1.
Example 8
This example provides a skin-repairing composition, which is different from example 1 only in that, in the absence of gentian root extract, the parts by weight of hypecoum vulgare extract were increased to 1.2 parts, the parts by weight of thermus thermophilus fermentation product was increased to 2.4 parts, and the parts by weight of chamomile flower extract was increased to 1.2 parts, and the other components and preparation method were the same as example 1.
Example 9
This example provides a skin-repairing composition, which is different from example 1 only in that, in the absence of the chamomile flower extract, the parts by weight of the hypsizygus marmoreus extract were increased to 1.2 parts, the parts by weight of the thermus thermophilus fermentation product were increased to 2.4 parts, and the parts by weight of the gentian root extract were increased to 1.2 parts, and the other components and preparation method were the same as example 1.
Example 10
This example provides a skin rejuvenation composition that differs from example 1 only in that, in the absence of ceramide NS/ceramide NG, the weight fraction of ceramide NP is increased to 1 part, the weight fraction of ceramide EOP is increased to 1 part, the weight fraction of ceramide AS is increased to 1 part, the weight fraction of ceramide AP is increased to 1 part, and the other components and preparation method are the same AS example 1.
Example 11
This example provides a skin rejuvenation composition which differs from example 1 only in that, without ceramide NP, the weight fraction of ceramide NS/ceramide NG was increased to 1 part, the weight fraction of ceramide EOP was increased to 1 part, the weight fraction of ceramide AS was increased to 1 part, the weight fraction of ceramide AP was increased to 1 part, and the other components and preparation method were the same AS example 1.
Example 12
This example provides a skin rejuvenation composition that differs from example 1 only in that, without ceramide EOP, the parts by weight of ceramide NS/ceramide NG was increased to 1 part, the parts by weight of ceramide NP was increased to 1 part, the parts by weight of ceramide AS was increased to 1 part, the parts by weight of ceramide AP was increased to 1 part, and the other components and preparation method were the same AS example 1.
Example 13
This example provides a skin rejuvenating composition, which differs from example 1 only in that, without ceramide AS, the weight fraction of ceramide NS/ceramide NG was increased to 1 part, the weight fraction of ceramide NP was increased to 1 part, the weight fraction of ceramide EOP was increased to 1 part, the weight fraction of ceramide AP was increased to 1 part, and the other components and preparation method were the same AS example 1.
Example 14
This example provides a skin rejuvenation composition that differs from example 1 only in that, without ceramide AP, the weight fraction of ceramide NS/ceramide NG was increased to 1 part, the weight fraction of ceramide NP was increased to 1 part, the weight fraction of ceramide EOP was increased to 1 part, the weight fraction of ceramide AS was increased to 1 part, and the other components and preparation methods were the same AS example 1.
Example 15
This example provides a skin rejuvenating composition which differs from example 1 only in that olive fruit oil is not included, the parts by weight of argan nut oil is increased to 12 parts, the parts by weight of squalane is increased to 12 parts, and the other components and preparation method are the same as example 1.
Example 16
This example provides a skin repair composition that differs from example 1 only in that argania spinosa kernel oil is not included, the number of parts by weight of olive fruit oil is increased to 12 parts, the number of parts by weight of squalane is increased to 12 parts, and the other components and preparation method are the same as example 1.
Example 17
This example provides a skin rejuvenating composition which differs from example 1 only in that squalane is not present, the parts by weight of olive fruit oil is increased to 12 parts, the parts by weight of argan nut oil is increased to 12 parts, and the other components and preparation method are the same as example 1.
Example 18
This example provides a skin rejuvenating composition that differs from example 1 only in that it does not contain shea butter, increasing the parts by weight of macadamia nut seed oil to 8 parts, and the other components and preparation method are the same as example 1.
Example 19
This example provides a skin rejuvenating composition that differs from example 1 only in that no macadamia nut seed oil is included, the parts by weight of shea butter is increased to 8 parts, and the other components and preparation method are the same as example 1.
Comparative example 1
This comparative example provides a skin-repairing composition, which is different from example 1 only in that it does not contain sodium DNA, the weight part of nicotinamide adenine dinucleotide is increased to 1.6 parts, and the other components and the preparation method are the same as example 1.
Comparative example 2
This comparative example provides a skin repair composition, which is different from example 1 only in that nicotinamide adenine dinucleotide is not contained, the weight part of the DNA sodium is increased to 1.6 parts, and the other components and the preparation method are the same as example 1.
Comparative example 3
This comparative example provides a skin repair composition, which differs from example 1 only in that it does not contain deforming vesicles, and a method for preparing the skin repair composition comprising the steps of: mixing water and active substances at 40 deg.C, and stirring at 60rpm for 1h; and homogenizing at 5000rpm for 5min to obtain the skin repairing composition.
Test example
Test example 1
Deformed vesicle transdermal absorption test
Testing a sample: example 1 denatured vesicle obtained in step (2).
The test method comprises the following steps: in vitro transdermal test materials using isolated bama pig skin as an in vitro transdermal test material, saline-ethanol (1), pH 5.8 phosphate buffer solution-ethanol (1), pH 7.4 phosphate buffer solution-ethanol (1) 2 Glass window composition) to determine the permeation and absorption rule of the deformed vesicle, and the LCMS/MS method is used to respectively determine the total absorption amount of the fluorescein in the receiving solution and the change behavior of the residual amount of the fluorescein in the pigskin along with the time, and evaluate the transdermal consistency of the test and the reference fluorescein.
FIG. 1 is a diagram of an in vitro transdermal absorption experiment of free fluorescein, and FIG. 2 is a diagram of an in vitro transdermal absorption experiment of fluorescein encapsulated in a deformed vesicle. From fig. 1 and 2, it can be seen that fluorescein encapsulated in deformed vesicles is much more permeable in the stratum corneum than free fluorescein.
Test example 2
Testing a sample: examples 1-19 and comparative examples 1-3 provide skin repair compositions.
The test method comprises the following steps:
the hair on the right hind foot was removed before test 1d by using 138 guinea pigs, male and female half, and the area of hair removed was about 2cm 2 The guinea pigs were randomly divided into 23 groups each containing 6 guinea pigs and recorded as examples 1-19 groups, comparative examples 1-3 groups and blank groups, respectively.
In the test, 0.05mL of the skin-repairing composition prepared in examples 1 to 19 and comparative examples 1 to 3 was applied to the dehaired parts of guinea pigs in examples 1 to 19 and comparative examples 1 to 3 continuously for 2 days, and an equal amount of deionized water was applied to the blank group 1 time a day.
On day 3, histamine phosphate solutions of 0.01% (w/v), 0.02% (w/v), 0.03% (w/v), 0.04% (w/v), 0.05% (w/v), 0.06% (w/v), 0.07% (w/v), 0.08% (w/v), 0.09% (w/v), and 0.1% (w/v) were prepared with physiological saline, respectively.
Coarse sand paper is used for scratching the hair-removed part of the dorsum of the right back foot of the guinea pig, and the scratching area is about 1cm 2 And locally applying the corresponding skin repair composition for 1 time, wherein the application volume is 0.05mL, applying an equal amount of deionized water to a blank group, after 10min, dropwise adding 0.05mL of 0.01% (w/v) histamine phosphate solution to the site of the scratch, observing whether the guinea pig returns to the head within 3min to lick the right hind paw, if the histamine phosphate solution does not exist, continuously dropwise adding 0.05mL of 0.02% (w/v) histamine phosphate solution to the site of the scratch, and observing whether the guinea pig returns to the head within 3min to lick the right hind paw. By analogy, the concentration is increased according to the gradient every 3min, 0.05mL of histamine phosphate solution is dripped every time until the guinea pig licks the right hind paw within 3 min. The cumulative total amount of histamine phosphate added dropwise at this time was taken as the itch threshold (μ g), the average value of the itch threshold of the same group of guinea pigs was calculated, and the data was collated, and the test results are shown in table 1:
TABLE 1
Group of | Itch threshold (mug) | Group of | Itch threshold (mug) |
Example 1 | 212.5 | Example 13 | 181.6 |
Example 2 | 209.8 | Example 14 | 182.0 |
Example 3 | 210.4 | Example 15 | 192.5 |
Example 4 | 163.2 | Example 16 | 189.8 |
Example 5 | 161.7 | Example 17 | 173.5 |
Example 6 | 154.8 | Example 18 | 179.9 |
Example 7 | 163.4 | Example 19 | 187.4 |
Example 8 | 156.2 | Comparative example 1 | 182.1 |
Example 9 | 153.8 | Comparative example 2 | 145.6 |
Example 10 | 184.5 | Comparative example 3 | 132.1 |
Example 11 | 180.4 | Blank group | 45.2 |
Example 12 | 182.7 |
As is clear from the data in Table 1, the skin repair composition provided by the invention has a certain inhibiting effect on skin itch of guinea pigs caused by histamine phosphate.
As is clear from comparison between example 1 and examples 4 to 9, madecassoside, an extract from calluses of Leontopodium alpinum, an extract from Criste maritime, a fermentation product of Thermus thermophilus, an extract from Gentiana scabra Bunge root and an extract from Matricaria chamomilla flower were found to cooperate with each other to synergistically inhibit itch of skin of guinea pigs caused by histamine phosphate.
As can be seen from a comparison of example 1 with examples 10 to 14, ceramide NS/ceramide NG, ceramide NP, ceramide EOP, ceramide AS and ceramide AP cooperate with each other to synergistically enhance adhesion between keratinocytes, improve skin dryness and maintain skin barrier.
As can be seen by comparing example 1 with examples 15-19, the olive fruit oil, the argan nut oil, squalane, shea butter and macadamia nut oil cooperate with each other to synergistically enhance the efficacy of the composition in repairing damaged skin, are easily absorbed by the skin, and have a refreshing and non-greasy feel in use.
As is clear from the comparison between example 1 and comparative examples 1-2, DNA sodium and nicotinamide adenine dinucleotide promote the metabolic turnover of cells, and thus both have a certain inhibitory effect on skin itch of guinea pigs caused by histamine phosphate.
As can be seen from a comparison between example 1 and comparative example 3, loading an active substance in a deformed vesicle makes the active substance more easily absorbed by the skin, and has a stronger barrier repair effect.
Test example 3
Test of fading effect
Testing a sample: examples 1-19 and comparative examples 1-3 provide skin repair compositions.
Reference is made to the literature (Wang-neck, anti-allergic and antipruritic plant combined extract preparation process, efficacy and action pathway research [ D ].2015 ]) method recorded in the 2.2.6 skin irritation repair experiment.
The specific method comprises the following steps: the subjects were divided into a total of 115 persons, 23 groups of 5 persons each, of which 1 group was blank, and the remaining 22 groups were tested for the skin-repairing compositions provided in examples 1 to 19 and comparative examples 1 to 3, respectively, and the specific gender configurations were randomly determined. The exclusion conditions of the volunteers meet the inclusion and exclusion standards of the diagnosis standard and the treatment principle of the cosmetic contact dermatitis.
Selecting the inner sides of the left and right arms of a subject as tested parts, and circularly marking a square area with the specification of 2cm multiplied by 2 cm; washing the test area (same area) with clear water, sitting the subject still for 10min, measuring the blank value of skin red value with Mexamter MX18 (pigment test probe) of CK company in Germany, and entering the smearing experiment stage; stimulating the tested area with 50% capsaicin water solution (about 0.01 mL); continuously stimulating for 15min and 30min, and collecting numerical value; smearing a test sample (0.05 mL, diluting the concentration to 10 mg/mL) on a tested area, and performing data acquisition after 15min, 30min and 45 min; smearing 0.05mL of pure water on the blank control; and (4) counting the average value of the values measured at each time of the experimental part of each group of subjects, and analyzing the change of the red value.
The change of the skin red value is reflected in the change rule of the skin redness of the experimental area along with the time in the testing period. The greater the value, the greater the degree of redness of the skin.
Skin redness change rate (%) = [ (T-T) Blank value )/T Blank value ]×100%。
Difference = skin redness change rate after 30min of stimulation-skin redness change rate after 45min of sample use;
the test results are shown in table 2 below:
TABLE 2
As can be seen from the data in table 2, the skin-repairing composition provided by the present invention has a repairing effect on skin irritation. By loading the active substance in the deformed vesicle, the transdermal absorption of the skin can be increased. The DNA sodium, the nicotinamide adenine dinucleotide, the ceramide, the natural product extract and the grease in the active substances are matched with each other, so that the synergistic effect is achieved, and the repair effect on the skin is improved.
Test example 4
Test of moisturizing Effect
Testing a sample: examples 1-19 and comparative examples 1-3 provide skin repair compositions.
110 skin-healthy 18-40-year-old volunteers were selected, male and female in half ratio, and randomly divided into 22 groups, and the skin-repairing compositions provided in examples 1 to 19 and comparative examples 1 to 3 were used, respectively. After cleaning face of volunteer, the ratio of 2mg/cm 2 The skin repair composition is weighed and then evenly smeared in a test area, the skin repair composition is used once after being washed on the face in the morning and continuously used for 30 days, and the water content of the skin of a volunteer before and after use is measured by a skin tester (MC 750, CK in Germany);
the moisture content of the facial skin of each subject was tested before use and after 30 days of continuous use, each data was tested three times, after taking the average value, the average value of each group was calculated, one digit after the decimal point was retained, and the rate of change of the moisture content of the skin was calculated according to the following formula:
change rate of moisture content of facial skin (%) = [ moisture content of facial skin 30 days after use-moisture content of facial skin before use)/moisture content of facial skin before use ] × 100%;
the test results are shown in table 3:
TABLE 3
As can be seen from the test results in table 3, the skin repair composition provided by the present invention can increase the transdermal absorption of the skin by loading the active substance into the deformed vesicles. The active substances are the mutual cooperation of DNA sodium, nicotinamide adenine dinucleotide, ceramide, natural product extract and grease, so that the synergistic effect is achieved, the facial water content is improved, and the skin moisturizing state is strengthened and restored.
As shown in fig. 3, the skin repair composition provided by the present invention can improve skin hydration, and exogenous hydration of stratum corneum (large amount of water) (moisture supplement) → stratum corneum dehydration (water evaporation) → stratum corneum structural compression rearrangement (compact order) → stratum corneum barrier function enhancement (better resistance to external stimuli)/transmittance is higher (smooth and transparent in appearance).
Test example 5 safety test
Cosmetic eye irritation test chick embryo chorioallantoic membrane test
Test samples: examples 1-19 and comparative examples 1-3 provide skin rejuvenation compositions.
The method comprises the following steps: T/SHRH 011-2018.
The principle method comprises the following steps: the chorioallantoic membrane (CAM) is a respiratory membrane that surrounds the chick embryo. Because the surface blood vessels of the chick embryo allantoic membrane are rich and can be regarded as a complete organism, the test utilizes the characteristics of complete, clear and transparent blood vessel system of chorioallantoic membrane in the middle stage of a hatched chick embryo, a certain amount of a test object is directly contacted with the chick embryo allantoic membrane, the change of chorioallantoic membrane toxicity effect indexes (such as bleeding, blood coagulation and blood vessel melting) is observed after the test object acts for a specified time, the score is given, and the mathematical average value is calculated for evaluating the eye irritation of the test object.
The detection method comprises the following steps: selecting fertilized chicken embryos of White Hangzhou chickens (White Leghorn chicken) and other varieties, incubating until the 8 th day, examining the eggs by an egg candler, discarding unfertilized and inactive chicken embryos, selecting chicken embryos with good blood vessel development, and marking the positions of air chambers on the surfaces of eggshells. The test was started on day 9. Carefully peeling off the eggshell part of the air chamber by dental bending, dripping a few drops of physiological saline on the surface of the eggshell membrane to fully wet the eggshell membrane, pouring out the eggshell membrane, and carefully removing the eggshell membrane by using a forceps to ensure that the exposed allantoic membrane is intact and does not suffer any damage. 0.3mL/0.3g of the test substance was applied directly to the CAM. Spread as much as possible to ensure coverage of at least 50%. After 3min of action, the CAM surface was gently rinsed with normal saline, the rinsing was completed within 30s, the liquid was decanted, the degree of change in each toxic effect was immediately observed under a stereomicroscope, and a score (ES) was given. Conditions allowed that pictures should be taken immediately after the 3min exposure was complete at the beginning of the observation.
The judgment basis is as follows: judged according to the score (ES). ES is less than or equal to 4 without stimulation, 4-Ap ES is less than or equal to 12 with mild stimulation, 12-Ap ES is less than or equal to 16 with moderate stimulation, and ES is more than or equal to 16 with severe stimulation.
The specific evaluation is shown in table 4 below:
TABLE 4
Each group of samples corresponds to 6 chick embryos, and the test result shows that ES of all test samples (the skin repair compositions provided by examples 1-19 and comparative examples 1-3) is less than or equal to 4 under the condition that the concentration of a test substance is 100 percent, so that the skin repair composition provided by the invention is safe and non-irritant.
The applicant states that the present invention is illustrated by the above examples of the process of the present invention, but the present invention is not limited to the above process steps, i.e. it is not meant that the present invention must rely on the above process steps to be carried out. It will be apparent to those skilled in the art that any modification of the present invention, equivalent substitutions of selected materials and additions of auxiliary components, selection of specific modes and the like, which are within the scope and disclosure of the present invention, are contemplated by the present invention.
Claims (10)
1. A skin rejuvenation composition comprising an amoebosome, water and an active agent loaded into said amoebosome, said active agent comprising sodium DNA, nicotinamide adenine dinucleotide, ceramide and a natural product extract.
2. The skin rejuvenation composition as defined in claim 1 wherein said skin rejuvenation composition includes, in parts by weight, 11 to 27 parts of deformed vesicles, 2 to 54 parts of water, and 35 to 88 parts of active agents carried in said deformed vesicles;
preferably, the active substance comprises 0.5-1 part of DNA sodium, 0.5-1 part of nicotinamide adenine dinucleotide, 2.5-5 parts of ceramide and 17-40 parts of natural product extract in parts by weight.
3. The skin rejuvenation composition as defined in claim 1 or 2 wherein said natural product extract comprises any one or a combination of at least two of madecassoside, alpine edelweiss callus extract, hypecoum extract, thermus thermophilus fermentation product, gentian root extract, or matricaria flower extract, preferably a combination of madecassoside, alpine edelweiss callus extract, hypecoum extract, thermus thermophilus fermentation product, gentian root extract, and matricaria flower extract;
preferably, the natural product extract comprises 5-15 parts by weight of madecassoside, 5-15 parts by weight of alpine edelweiss callus extract, 0.5-1 part by weight of hypecoum extract, 1-3 parts by weight of thermophilic thermus fermentation product, 0.5-1 part by weight of gentian extract and 0.5-1 part by weight of chamomile flower extract.
4. The skin rejuvenation composition AS defined in any one of claims 1 to 3 wherein said ceramide comprises any one or a combination of at least two of ceramide NS/ceramide NG, ceramide NP, ceramide EOP, ceramide AS, or ceramide AP, preferably a combination of ceramide NS/ceramide NG, ceramide NP, ceramide EOP, ceramide AS, and ceramide AP;
preferably, the ceramide comprises 0.5-1 part of ceramide NS/ceramide NG, 0.5-1 part of ceramide NP, 0.5-1 part of ceramide EOP, 0.5-1 part of ceramide AS and 0.5-1 part of ceramide AP by weight.
5. The skin rejuvenation composition as claimed in any one of claims 1 to 4 wherein said active substance further includes an oil;
preferably, the oil comprises any one or a combination of at least two of olive fruit oil, argan tree kernel oil, squalane, shea butter or macadamia nut seed oil, preferably the combination of olive fruit oil, argan tree kernel oil, squalane, shea butter and macadamia nut seed oil;
preferably, the grease comprises, by weight, 5-10 parts of olive fruit oil, 5-10 parts of argania spinosa kernel oil, 5-10 parts of squalane, 1-5 parts of shea butter and 1-5 parts of macadamia nut seed oil;
preferably, the active substance further comprises 1, 2-hexanediol;
preferably, the active substance also comprises 2-5 parts of 1, 2-hexanediol according to parts by weight.
6. The skin rejuvenating composition as claimed in any one of claims 1 to 5 wherein the proteoliposomes are prepared from materials including PEG/PPG-14/7 dimethyl ether, polyglycerol ester surfactants, sorbitan ester surfactants, cetyl phosphate, honokiol and magnolol;
preferably, the raw materials for preparing the deformed vesicle comprise, by weight, 2-5 parts of PEG/PPG-14/7 dimethyl ether, 4-10 parts of polyglycerol ester surfactant, 2-5 parts of sorbitan ester surfactant, 1-3 parts of cetyl alcohol phosphate, 1-2 parts of honokiol and 1-2 parts of magnolol;
preferably, the polyglycerol ester surfactant comprises a polyglycerol-6 ester of wild almond oil and/or polyglycerol-10 oleate, preferably a combination of a polyglycerol-6 ester of wild almond oil and polyglycerol-10 oleate;
preferably, the sorbitan ester surfactant comprises sorbitan palmitate;
preferably, the mass ratio of the magnolol to the polyglycerol ester surfactant is 1 (2-10).
7. A method of preparing a skin rejuvenating composition as claimed in any one of claims 1 to 6, which comprises the steps of: mixing the deformed vesicle, water and the active substance, stirring and homogenizing to obtain the skin repair composition.
8. The method of claim 7, wherein the temperature of the mixing is 35-45 ℃;
preferably, the rotation speed of the stirring is 50-70rpm, and the time is 0.8-1.2h;
preferably, the homogenizing speed is 4500-5500rpm for 4-6min.
9. The method for producing an amoebosome according to claim 7 or 8, wherein the method for producing an amoebosome comprises the steps of:
(1) Mixing polyglycerol ester surfactant, sorbitan ester surfactant and cetyl phosphate, and stirring to obtain bilayer;
(2) Mixing the bilayer obtained in the step (1), PEG/PPG-14/7 dimethyl ether, honokiol and magnolol, and stirring to obtain the deformed vesicle;
preferably, in step (1), the temperature of the mixing is 55-65 ℃;
preferably, in the step (1), the rotation speed of the stirring is 45-55rpm, and the time is 20-40min;
preferably, in the step (2), the temperature of the mixing is 40-50 ℃;
preferably, in the step (2), the rotation speed of the stirring is 35-45rpm, and the time is 20-40min.
10. Use of a skin repair composition according to any one of claims 1 to 6 in the preparation of a skin care product;
preferably, the skin care product comprises a cream and/or a serum.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211028535.0A CN115154403B (en) | 2022-08-25 | 2022-08-25 | Skin repair composition and preparation method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211028535.0A CN115154403B (en) | 2022-08-25 | 2022-08-25 | Skin repair composition and preparation method and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN115154403A true CN115154403A (en) | 2022-10-11 |
CN115154403B CN115154403B (en) | 2023-04-18 |
Family
ID=83481514
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211028535.0A Active CN115154403B (en) | 2022-08-25 | 2022-08-25 | Skin repair composition and preparation method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115154403B (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116115519A (en) * | 2022-12-30 | 2023-05-16 | 水羊化妆品制造有限公司 | Antibacterial composition and application thereof |
CN116898790A (en) * | 2023-08-15 | 2023-10-20 | 广东丸美生物技术股份有限公司 | Composition with anti-wrinkle repairing effect and application thereof |
CN119174712A (en) * | 2024-11-22 | 2024-12-24 | 拉芳家化股份有限公司 | NAD+ composition for skin anti-aging compact cosmetic and preparation process thereof |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104622723A (en) * | 2015-02-06 | 2015-05-20 | 深圳唯美度生物科技有限公司 | Face-thinning BB cream and preparation method thereof |
CN107049903A (en) * | 2017-05-16 | 2017-08-18 | 曼秀雷敦(中国)药业有限公司 | A kind of cream for sensitive skin and preparation method thereof |
CN110433089A (en) * | 2018-05-04 | 2019-11-12 | 科丝美诗株式会社 | For promote skin absorb vesica with and preparation method thereof |
CN110664650A (en) * | 2019-10-25 | 2020-01-10 | 王毅 | Multi-effect skin care composition and essence and preparation method thereof |
CN111450003A (en) * | 2020-04-21 | 2020-07-28 | 圣迪斯哥(深圳)生物科技有限公司 | Anti-aging and beautifying nutrient containing golden fragrant willow extract, preparation method thereof, essence and extraction method of golden fragrant willow extract |
CN113025680A (en) * | 2021-03-15 | 2021-06-25 | 杭州优玛达生物科技有限公司 | Method for fermentation conversion of madecassoside and application thereof |
CN113244130A (en) * | 2021-04-30 | 2021-08-13 | 苏州纳康生物科技有限公司 | Ultra-strong oxidation-resistant deformable vesicle and preparation method and application thereof |
-
2022
- 2022-08-25 CN CN202211028535.0A patent/CN115154403B/en active Active
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104622723A (en) * | 2015-02-06 | 2015-05-20 | 深圳唯美度生物科技有限公司 | Face-thinning BB cream and preparation method thereof |
CN107049903A (en) * | 2017-05-16 | 2017-08-18 | 曼秀雷敦(中国)药业有限公司 | A kind of cream for sensitive skin and preparation method thereof |
CN110433089A (en) * | 2018-05-04 | 2019-11-12 | 科丝美诗株式会社 | For promote skin absorb vesica with and preparation method thereof |
CN110664650A (en) * | 2019-10-25 | 2020-01-10 | 王毅 | Multi-effect skin care composition and essence and preparation method thereof |
CN111450003A (en) * | 2020-04-21 | 2020-07-28 | 圣迪斯哥(深圳)生物科技有限公司 | Anti-aging and beautifying nutrient containing golden fragrant willow extract, preparation method thereof, essence and extraction method of golden fragrant willow extract |
CN113025680A (en) * | 2021-03-15 | 2021-06-25 | 杭州优玛达生物科技有限公司 | Method for fermentation conversion of madecassoside and application thereof |
CN113244130A (en) * | 2021-04-30 | 2021-08-13 | 苏州纳康生物科技有限公司 | Ultra-strong oxidation-resistant deformable vesicle and preparation method and application thereof |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116115519A (en) * | 2022-12-30 | 2023-05-16 | 水羊化妆品制造有限公司 | Antibacterial composition and application thereof |
CN116898790A (en) * | 2023-08-15 | 2023-10-20 | 广东丸美生物技术股份有限公司 | Composition with anti-wrinkle repairing effect and application thereof |
CN116898790B (en) * | 2023-08-15 | 2024-04-05 | 广东丸美生物技术股份有限公司 | Composition with anti-wrinkle repairing effect and application thereof |
CN119174712A (en) * | 2024-11-22 | 2024-12-24 | 拉芳家化股份有限公司 | NAD+ composition for skin anti-aging compact cosmetic and preparation process thereof |
Also Published As
Publication number | Publication date |
---|---|
CN115154403B (en) | 2023-04-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN115154403B (en) | Skin repair composition and preparation method and application thereof | |
CN109846757B (en) | Sebum biomimetic composition and cosmetic containing same | |
JP7083090B2 (en) | Pore-specific beauty essence with EVERYCO extract added and its preparation method | |
JP7245960B2 (en) | Composition and its use in the manufacture of skin care products for regulating skin biorhythms | |
CN110787091B (en) | Itching-relieving and anti-allergy infant washing and protecting preparation and application thereof | |
KR101500191B1 (en) | Skin care compositions and method for manufacturing the same | |
CN113599319A (en) | Multi-effect nursing cosmetic composition for infants | |
CN113425661B (en) | Plant composition with cleaning and repairing effects and application thereof | |
CN105342914A (en) | Spot-removing whitening astringent toner and preparation method thereof | |
CN112107533B (en) | Composition with effects of controlling oil, tendering skin and collecting fine hair pores, and preparation method and application thereof | |
CN115282108B (en) | A composition with high-efficiency soothing effect and its application | |
CN113041172A (en) | Skin lipid membrane bionic composition for skin barrier repair and application thereof and cosmetic | |
CN110302121B (en) | A kind of baby nipple cream containing plant essence and preparation method thereof | |
CN110623899A (en) | Rice-derived skin care composition and preparation method thereof | |
TWI729618B (en) | Use of phalaenopsis plant extract for anti-glycation and improving skin appearance | |
CN116251047B (en) | Oil-control hair-washing agent containing burdock root extract and preparation method thereof | |
CN116850081A (en) | Repairing composition for sensitive muscles, freeze-dried mask and preparation method thereof | |
CN113171316B (en) | Cosmetic for repairing and relieving skin irritation and preparation method thereof | |
CN108888573B (en) | Soothing and moisturizing cream and preparation method thereof | |
CN113143788A (en) | Multi-effect composition and face cream with moisturizing, repairing and relieving functions | |
CN111904905A (en) | A cosmetic lotion containing marigold petal and multiple plant extracts | |
CN117860624B (en) | Bionic sebum membrane composition with relieving effect and preparation method thereof | |
JP2007008912A (en) | Beauty treatment method for maintaining life rhythm homeostasis | |
CN118384049B (en) | Highly moisturizing bath cream with skin repairing effect and preparation method thereof | |
CN115778872B (en) | Composition with acne removing and repairing effects, and preparation method and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP03 | Change of name, title or address |
Address after: Room 501, 5th Floor, Industrial Innovation Park, High tech Zone, Building 2, No. 19 Ketai Second Road, Guangzhou Private Science and Technology Park, Baiyun District, Guangzhou City, Guangdong Province, 510000 Patentee after: Archimedes (Guangzhou) Cosmetics Research Co.,Ltd. Address before: Room 1514, No. 359, Nanhua Road, Qiaonan Street, Panyu District, Guangzhou City, Guangdong Province, 510400 Patentee before: Guangzhou Archimedes Biotechnology Co.,Ltd. |
|
CP03 | Change of name, title or address |